EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship

Roberto Borea iD, Luca Arecco iD, Simone Nardin, Edoardo Chiappe, Chiara Lanzavecchia, Mónica Fragío Gil iD, Arianna Meacci, Giang Pham Hoang iD, Luiza Nardin Weis, Luciana de Moura Leite, Valentina Eva Klocker, Pedro Freire iD und 5 weitere

Therapeutic Advances in Medical Oncology · 2025-09 · 17

DOI: 10.1177/17588359251368733 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 17.09.2025. Verfasst von Roberto Borea und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most frequent malignancy among young women, with unique challenges particularly for carriers of BRCA pathogenic or likely pathogenic variants (PVs). Among them, the indication for intensive surveillance and risk-reducing surgeries is critical. In addition, special considerations on systemic treatment should be considered, including the use of targeted treatments like poly (adenosine diphosphate (ADP)-ribose) polymerase inhibitors. Moreover, the impact of anticancer treatments and risk-reducing surgeries on their ovarian reserve, pregnancy wish, and breastfeeding is a crucial aspect to be considered. Proper management of long-term toxicities, such as bone and cardiovascular health, as well as menopause-related symptoms, requires proper multidisciplinary care to optimize quality of life. This review examines the biological, clinical, therapeutic, and survivorship implications of breast cancer in young BRCA carriers, emphasizing differences between carriers of PVs in the BRCA1 and BRCA2 genes. Personalized strategies integrating genetic counseling, tailored surveillance and survivorship programs, as well as innovative therapies, are essential for improving prognosis and well-being in these young patients. Multidisciplinary care and further academic research efforts are critical to improve the management of breast cancer in young BRCA carriers.

Schlagwörter

Stichwörter der Autor:innen

BRCAbreast cancergenetic testtreatmentyoung

Autor:innen und Institutionen

  • Department of Medical Oncology, Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.
  • Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Academic Trials Promoting Team, Bruxelles, Belgium.
  • Department of Medical Oncology, Hospital Universitario Parc Tauli, Sabadell, Spain.
  • Department of Translational and Precision Medicine, Tor Vergata University of Rome, Rome, Italy.
  • Department of Oncology, Vinmec International General Hospital, Hanoi, Vietnam.

ORCID-Profile: Roberto Borea, Luca Arecco, Mónica Fragío Gil, Giang Pham Hoang, Pedro Freire, Matteo Lambertini

Zitieren

APA

Borea, R., Arecco, L., Nardin, S., Chiappe, E., Lanzavecchia, C., Fragío Gil, M., Meacci, A., Pham Hoang, G., Nardin Weis, L., de Moura Leite, L., Klocker, V. E., Freire, P., Brunetti, N., Trevisan, L., Buzzatti, G., Spinaci, S., & Lambertini, M. (2025). Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship. Therapeutic Advances in Medical Oncology, 17. https://doi.org/10.1177/17588359251368733

Vancouver

Borea R, Arecco L, Nardin S, Chiappe E, Lanzavecchia C, Fragío Gil M, et al. Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship. Therapeutic Advances in Medical Oncology. 2025;17. doi:10.1177/17588359251368733

BibTeX
@article{Borea2025,
  author = {Borea, Roberto and Arecco, Luca and Nardin, Simone and Chiappe, Edoardo and Lanzavecchia, Chiara and Fragío Gil, Mónica and Meacci, Arianna and Pham Hoang, Giang and Nardin Weis, Luiza and de Moura Leite, Luciana and Klocker, Valentina Eva and Freire, Pedro and Brunetti, Nicole and Trevisan, Lucia and Buzzatti, Giulia and Spinaci, Stefano and Lambertini, Matteo},
  title = {Early breast cancer in young BRCA carriers: from diagnosis to treatment and survivorship},
  journal = {Therapeutic Advances in Medical Oncology},
  year = {2025},
  volume = {17},
  doi = {10.1177/17588359251368733}
}
Kostenlos starten →